Anna Wojtalla, Barbara Fischer, Nataliya Kotelevets, Francesco A Mauri, Jens Sobek, Hubert Rehrauer, Carlos Wotzkow, Mario P Tschan, Michael J Seckl, Uwe Zangemeister-Wittke, Alexandre Arcaro
{"title":"更正:靶向磷酸肌肽3-激酶p110-α亚型会损害小细胞肺癌的细胞增殖、存活和肿瘤生长。","authors":"Anna Wojtalla, Barbara Fischer, Nataliya Kotelevets, Francesco A Mauri, Jens Sobek, Hubert Rehrauer, Carlos Wotzkow, Mario P Tschan, Michael J Seckl, Uwe Zangemeister-Wittke, Alexandre Arcaro","doi":"10.1158/1078-0432.CCR-25-0031","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"31 4","pages":"787"},"PeriodicalIF":10.2000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction: Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer.\",\"authors\":\"Anna Wojtalla, Barbara Fischer, Nataliya Kotelevets, Francesco A Mauri, Jens Sobek, Hubert Rehrauer, Carlos Wotzkow, Mario P Tschan, Michael J Seckl, Uwe Zangemeister-Wittke, Alexandre Arcaro\",\"doi\":\"10.1158/1078-0432.CCR-25-0031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10279,\"journal\":{\"name\":\"Clinical Cancer Research\",\"volume\":\"31 4\",\"pages\":\"787\"},\"PeriodicalIF\":10.2000,\"publicationDate\":\"2025-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Cancer Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/1078-0432.CCR-25-0031\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1078-0432.CCR-25-0031","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Cancer Research is a journal focusing on groundbreaking research in cancer, specifically in the areas where the laboratory and the clinic intersect. Our primary interest lies in clinical trials that investigate novel treatments, accompanied by research on pharmacology, molecular alterations, and biomarkers that can predict response or resistance to these treatments. Furthermore, we prioritize laboratory and animal studies that explore new drugs and targeted agents with the potential to advance to clinical trials. We also encourage research on targetable mechanisms of cancer development, progression, and metastasis.